Hair Loss

 

Hair loss (alopecia) can be, but is not always, a side effect of certain chemotherapy drugs. Your health care team will tell you before you start treatment whether you can expect to lose your hair. Hair loss typically begins 2 or 3 weeks after chemotherapy treatment starts.

You may experience thinning or loss of hair on your head, underarms, and leg, and the loss or reduction of your eyebrows, eyelashes, facial hair, and pubic hair. The amount of hair you lose is related to the type of chemotherapy you receive. The good news is that your hair will grow back—typically 1 to 2 months after chemotherapy ends. It may take 6 months or more for your hair to fully grow back.

It can be difficult to prepare yourself for the loss of your hair. This change in your self-image is often a visual reminder to you and others that you are undergoing treatment for cancer. It’s OK to allow yourself to grieve the loss of your hair. Encourage family members, especially children, to express their thoughts and emotions about your hair loss. Remember, losing your hair does not change who you are as a person. You are still you.

Tips for Dealing with Hair Loss

  • Get a short haircut before you begin treatment. It may help you adjust to and manage the loss.
  • Shop for a wig before your hair is gone, especially if you wish to match your natural color. (Be sure to ask your insurance company if it covers the cost of a wig.)
  • Be gentle with your hair. Use mild shampoos and soft hair brushes. Avoid chemicals, including bleach, peroxide, or hair dye.
  • Remember to cover your head or use sunscreen (with an SPF of at least 15) on your scalp. Your skin may be particularly sensitive to ultraviolet (UV) rays.
  • Shaving your head before your hair starts to fall out can give you a sense of control over your situation.
  • Besides wigs, try hats, scarves, and turbans. You may prefer these to a wig. Or you may decide not to cover your head at all. It’s up to you.
  • There are programs that teach makeup and accessorizing techniques to cancer patients. Ask your health care team for information.
This content was last modified on August 29, 2007 .
Latest Cancer News
ACOG Updates Cervical Cancer Screening Guidelines

November 20, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

New Velcade®-melphalan Transplant Regimen for Multiple Myeloma

November 20, 2009 — Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.

Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient

November 20, 2009 — Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.

Select news items provided by Reuters Health